Podcasts about clinical excellence nice

In this episode Rosey interviews Dr. Adam Fox, a paediatric allergist. They discuss what causes allergies, touching on how genetics and the environment play a part. Adam shares insights on introducing potential allergens like peanuts and eggs early in a child's diet to help reduce allergy risks. They talk about eating nuts during pregnancy, and the importance of managing eczema.Adam fills Rosey in on allergy testing and diagnosis, stressing the importance of getting it right for better management and avoiding unnecessary food restrictions. This episode is all about giving parents the know-how to handle their kids' allergies for better sleep and happier families. Professor Adam Fox read Medicine and Neuroscience at Cambridge University before completing his clinical training at University College, London. After specialist training in Paediatric Allergy in 2006, he spent 9 years as clinical lead for Allergy (Adult & Paediatric) at Guy's & St Thomas' Hospitals, London – obtaining recognition as an International Centre of Excellence by both the World Allergy Organisation and GALEN (European Asthma & Allergy Network). After 3 years as Clinical Director for Specialist Ambulatory Medicine, he was appointed Deputy Medical Director for Guy's & St Thomas' Hospitals NHS Foundation Trust in 2018. Adam is a consultant Paediatric Allergist at Evelina London Children's Hospital and Professor of Paediatric Allergy at King's College London. He was the founding Director of the KCL Allergy Academy, a postgraduate educational programme, which was a finalist at the BMJ Awards in 2018. Adam chaired the UK Department of Health National Care Pathway for Food Allergy in Childhood and was a member of the National Institute of Healthcare and Clinical Excellence (NICE) clinical guideline development group for the assessment and diagnosis of food allergy in children. He previously chaired the Paediatric Committee of the British Society of Allergy & Clinical Immunology (BSACI) and was elected as BSACI President, the first Paediatrician to hold this position, from October 2018 until 2021. He remains a trustee and Immediate Past President of BSACI and in July 2022 was appointed at Chair of the National Allergy Strategy Group. Adam was awarded ‘Paediatric Allergist of the Year' from Allergy UK in 2007. His doctoral thesis on peanut allergy received the Raymond Horton Smith prize from Cambridge University in 2012 and he was included in The Times ‘Britain's 100 Best Children's Doctors' (2012). Adam received the William Frankland Award for Outstanding contribution to Allergy from the British Society of Allergy & Clinical Immunology in 2015 and a National Clinical Excellence award from the UK Department of Health in 2016 and 2020. He was also listed in the most recent ‘The Tatler Doctors List' (2013) of the best 250 UK private medical consultants. In 2024, Adam became only the second person to receive the BSACI Fellows Award in recognition of outstanding contribution to clinical allergy. Adam's private practice is Allergy London and he posts regularly about allergy related issues on Instagram ‘@DrAdamFox.'

This week ⁠Sarah⁠ continues to fly solo on the podcast with a deep dive into breast cancer with the largest breast cancer charity in the UK, Breast Cancer Now. Sarah is joined by Sally Kum who is the Associate Director of Nursing, Healthcare, Professional Engagement and Health Information who talks about the incredible work done by the charity around research, funding and support for anyone affected by breast cancer. Sally shares some of the latest findings that show breast cancer diagnoses are increasing in the UK and she explains some of the different types of breast cancer. This episode was recorded on 29th July which by chance was the same day on which the the National Institute of Clinical Excellence (NICE) announced the NHS would not be making the drug Enhertu available to patients in England. Enhertu is a life-extending drug for certain women with incurable HER2-low secondary breast cancer, and in an emotional moment, Sarah explores the impact of this and how you can have your voice heard through an online petition. You can read the Enhertu announcement from NICE here. We'd like to hear about your experiences with cancer, so please do get in touch if you'd like to share. If you're listening on Spotify, you can use the show's Q&A feature, or please share your thoughts through our Instagram page at ⁠@howlonghaveyougot2024⁠. And please do like and recommend the show as it helps us reach more members of the cancer community. Studio and recording by ⁠A Digital⁠. Production for A Digital by ⁠Andrew Armitage⁠.

In this episode of Better Thinking, Nesh Nikolic speaks with Dr Mark Horowitz about exploring expert strategies for tapering off SSRIs and managing withdrawal symptoms. Dr Mark Horowitz MBBS PhD is a Clinical Research Fellow in Psychiatry in the National Health Service (NHS) in England and an Honorary Research Fellow at University College London (UCL) and a trainee psychiatrist. He runs a deprescribing clinic in the NHS helping people to stop psychiatric medications. He co-authored the Royal College of Psychiatry guidance on “Stopping Antidepressants”, and his work informed the recent National Institute for Clinical Excellence (NICE) guidelines on safe discontinuation of psychiatric medications. He also published work on how to safely taper antipsychotics in JAMA Psychiatry and Schizophrenia Bulletin. He has authored chapters of the Maudsley Prescribing Guidelines on how to stop mood stabilisers, antidepressants, antipsychotics, benzodiazepines, z-drugs and gabapentinoids. He is currently writing the Maudsley Deprescribing Guidelines in Psychiatry which will be published in 2023. He is Co-Investigator on the RELEASE trial in Australia evaluating the effect of gradual, hyperbolic tapering of antidepressants compared to care as usual. He has an interest in rational psychopharmacology and deprescribing psychiatric medication. He has experienced the difficulty of coming off psychiatric medications first-hand which has informed much of his work. His work can be found at https://markhorowitz.org/ Episode link at https://neshnikolic.com/podcast/mark-horowitzSee omnystudio.com/listener for privacy information.

In this episode, Dr Natalie Lancer talks to Dr Andrew Marren, Natalie Silverdale and Dr Andrew Parsons. Natalie Silverdale and Dr Andrew Parsons are part of the team behind the pioneering concept of coaching cancer patients at The Fountain Centre, a cancer charity located at St Luke's Cancer Centre at the Royal Surrey Hospital. Dr Andrew Marren researched the ‘therapeutic coaching' happening at the Fountain Centre for his doctorate. We discuss: How did the coaching service at The Fountain Centre get started? How does coaching support cancer patients? How does coaching fit into other holistic and emotional services offered to patients? How is the coaching delivered and in what format? How did The Fountain Centre develop a framework of standards and ethics for coaching cancer patients? How does the coaches' learning and development inform the coaching services offered to patients? What are the key research findings from the patients' and coaches' perspective? What does The Fountain Centre look for in volunteer coaches? How do supervision and self-care practices support the volunteer coaches? How might ‘therapeutic coaching' fit into existing National Institute for Clinical Excellence (NICE) guidance on Cancer Services? The case study of The Fountain Centre demonstrates how coaching is a service that can be offered in addition to counselling and other forms of support. The impact of this service has been recognised by NHS England who are using the approach to develop National Standards for coaching in cancer. In this conversation, we discuss how as well as improving palliative care for people with cancer, coaching in hospitals may well benefit other patients. Our guests today are: Dr Andrew Marren undertook his PhD at the University of Portsmouth as a collaborative project with The Fountain Centre cancer charity. The PhD focused on exploring the impact of coaching cancer patients, from both the coaches' and patients' perspectives. He previously completed an ILM Level 3 Certificate in Coaching and Mentoring and an MSc in Work Psychology. He worked on a coaching project at University of South Wales, exploring the training needs of academic staff. He is currently employed at the University of Winchester as a Lecturer in Psychology and researches coaching in cancer care, advocating for coaching as an emotional support intervention. Natalie Silverdale has been working in the field of cancer and end of life care for over 25 years. Since 2015, she has worked for The Fountain Centre. She is a qualified coach in the Centre and Head of Research and Development. She has worked extensively in palliative care services, undertaking a national evaluation of the Marie Curie Nursing Service, working as Head of Research and Policy for the Dignity in Dying and working as researcher on Lord Joel Joffe's Assisted Dying for the Terminally Ill Bill that was subject to a House of Lords Select Committee in 2004/5.  Dr Andrew Parsons is an Accredited Master Coach and Certified Wellness Practitioner with speciality in Psychology, Neuroscience and Physiology.  He is an experienced holistic therapist and registered with the Complementary and Natural Healthcare Council (Hypnotherapy). He was the founding coach at The Fountain Centre. He is a member of the National Wellness Institute's multi-cultural competency committee and the Chair of the EMCC UK Health and Wellbeing special interest group. He has over 100 peer reviewed scientific publications and has co-authored, Empowerment in Health and Wellness. Your host, Dr Natalie Lancer, is a Chartered Coaching Psychologist, and British Psychological Society (BPS) Registered Supervisor. She is the Chair of the BPS's Division of Coaching Psychology and an accredited member of the Association for Coaching. She is the host of this podcast series and invites you to email any comments to docp-tcppod@bps.org.uk https://www.bps.org.uk/member-networks/division-coaching-psychology © British Psychological Society 2023

5. Versarien #VRS - BiaBrazil to utilise Graphene-Wear Technology BiaBrazil, a leading Brazilian sports and active wear manufacturer, has announced it has signed a commercial agreement with Versarien which will see the integration of Versarien's Graphene-Wear™ technology into a new range of women and men's active wear garments. 4. Guild Esports #GILD - Guild's largest sponsorship deal signed with Sky This deal is Guild's largest to date and is payable exclusively in cash via instalments over the period of the contract. It is the eighth revenue-generating sponsorship signed by the Company since its IPO on the London Stock Exchange. 3. Genedrive #GDR - NICE to accelerate evaluation of Genedrive test The UK's National Institute for Health and Clinical Excellence ("NICE") has transferred the evaluation of the Genedrive® MT-RNR1 test to a new Early Value Assessment Programme. 2. Vast Resources #VAST - Placing to raise £656,000 and Baita Plai Operational Update The net cash raised will ensure the Company's operations continue to be supported over the coming weeks as a consequence of a delay in exporting its latest concentrate shipment, as well as the start of the underground production ramp up occurring later in Q3 2022 than originally anticipated. 1. Avacta Group #AVCT - Notice of Results Its unaudited interim results for the six months ended 30 June 2022 will be released on 29 September 2022.

Professor Dame Parveen Kumar is Emeritus Professor of Medicine and Education at Barts and a consultant gastroenterologist. She has had an immensely successful career as a researcher, medical educator, leader and clinician. Professor Kumar was appointed as a Non-Executive Director of the National Institute of Clinical Excellence (NICE) at its inception in 1999 and resigned this post in 2002 when she was appointed as the Chairman of the Medicines Commission UK. She has been President of the British Medical Association, President of the Royal Society of Medicine and vice president of the Royal College of Physicians. She was awarded DBE for services to Medicine. Perhaps she is best known for her incredible textbook “Kumar and Clark's clinical medicine”, now in its 10th edition and used by medical students and doctors worldwide.   During this episode we discuss: Her career Gastroenterology Her flagship textbook Leadership Advice for medical students and doctors For comments, collaboration or feedback, contact us via email or Twitter. Email: medspirepodcast@gmail.com Twitter: @medspirepodcast

Dr Eugene Oteng-Ntim presents a short podcast on the Guideline on Management of sickle cell disease in pregnancy. The purpose of this guideline is to describe the management of sickle cell disease (SCD) in pregnancy in the UK. It will cover the following: preconception screening and antenatal Intrapartum and postnatal management of women with the condition. It will not cover the management of women with sickle cell trait. Updates from the previous guideline1 include new information on pre-implantation genetic diagnosis (PGD), more comprehensive information on pre-conceptual screening and medication review, updated information on thromboprophylaxis, aspirin and vitamin D, changes to advice on antenatal care including frequency of ultrasonography (USS) scanning. It also includes reference to the most recent National Institute for Health and Clinical Excellence (NICE) and RCOG guidelines.  Also, this guideline was presented at the Guidelines Session at the ASM 2021 and the presentation can be found in our list of podcasts. Dr Oteng-Ntim is a Consultant Obstetrician and Head of Obstetrics at Guy's and St Thomas NHS Trust Foundation. He is a Honorary Reader in Women's Health (KCL) and Honorary Associate Professor in Epidemiology and Population Health (LSHTM).

Off the back of the Society for Acupuncture Research (SAR) conference (2021), in this episode Nick and Spod will be discussing the current state of the evidence-base for acupuncture. They will be exploring questions including:Where is the evidence strongest and where is there potential?What are some of the key issues in the field such as placebo?Where does the future of acupuncture research lie?References from the show:Efficacy for chronic pain (MacPherson and Charlesworth, 2020; Vickers et al., 2018):https://pubmed.ncbi.nlm.nih.gov/29198932/ and https://pubmed.ncbi.nlm.nih.gov/33362893/Efficacy for migraines (Zhao et al., 2017): https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2603492UK NICE guidelines chronic pain (National Institute for Clinical Excellence NICE, 2021):https://www.nice.org.uk/guidance/ng193/evidence/acupuncture-in-people-with-chronic-primary-pain-pdf-9075291805Acupuncture and mechanical placebos (Kaptchuk, 2020): https://pubmed.ncbi.nlm.nih.gov/33362886/Future directions for acupuncture research (Schnyer and Hullender Rubin, 2020): https://pubmed.ncbi.nlm.nih.gov/33362894/Acupuncture reducing risk of coronary heart disease in osteoarthritis patients (Ton et al., 2021): https://pubmed.ncbi.nlm.nih.gov/32744906/Acupuncture and anti-inflammatory pathways (Liu et al., 2020): https://pubmed.ncbi.nlm.nih.gov/32791039/Acupuncture for carpal tunnel syndrome (Maeda et al., 2017): https://pubmed.ncbi.nlm.nih.gov/28334999/Acupuncture and fibromyalgia RCT and neuroimaging (Mawla et al., 2021): https://pubmed.ncbi.nlm.nih.gov/33314799/

When it comes to the field of Suicidology, we often work in silos. The researchers, clinicians, public health practitioners, advocates, and crisis service stakeholders often focus primarily in their own communities, finding comfort and validation in joining with others who share similar culture, values and priorities. When it comes to groups implementing best practices, collaboration with researchers is essential. In this interview I speak with internationally renowned expert on suicide and self-harm, Prof. Nav Kapur from the University of Manchester, United Kingdom. We discuss some of the tensions and opportunities that we face as we bridge research to practice.About Prof. Nav KapurNav is Professor of Psychiatry and Population Health at the University of Manchester, UK and an Honorary Consultant Psychiatrist at Greater Manchester Mental Health NHS Foundation Trust. He has spent the last 25 years researching suicidal behaviour, particularly its causes, treatment and prevention. He has led committees for the National Institute for Health and Clinical Excellence (NICE) in the UK including those developing guidelines for how all clinical staff should treat people with self-harm. He sits on the main advisory group on suicide for the Department of Health in England and is currently helping to lead a national quality improvement project to prevent suicide. He is the lead author of Suicide Prevention (3rd Edition, Oxford University Press) and has published over 300 academic papers. He is the 2021 recipient of the American Association of Suicidology's Louis I. Dublin Award for lifetime achievement in suicide prevention. For more information on this episode go to https://www.sallyspencerthomas.com/hope-illuminated-podcast/85

Amy and Cerys talk to Jo, a recovering anorexic from Birmingham, and Dr. Nicky Gilbert, a clinical psychologist working at Sussex Eating Disorders Services (SEDS).Help with eating disordersBeat Helpline: 0808 801 0677 Studentline: 0808 801 0811 Youthline: 0808 801 0711 Web chat also available: https://www.beateatingdisorders.org.uk/support-servicesFreedhttps://freedfromed.co.uk/NHShttps://www.nhs.uk/mental-health/feelings-symptoms-behaviours/behaviours/eating-disorders/overview/Help for boys and men with eating disorders Male VoicEDhttps://www.malevoiced.com/Guidance on contacting your GPhttps://www.beateatingdisorders.org.uk/uploads/documents/2017/10/gp-leaflet-website.pdfEating disorders and the pandemichttps://www.theguardian.com/society/2021/feb/11/doctors-warn-of-tsunami-of-pandemic-eating-disordershttps://www.itv.com/thismorning/articles/the-rise-of-eating-disorders-in-lockdownBooksUnbearable Weight: Feminism, Western Culture, and the Body by Susan BordoDecoding Anorexia: How Breakthroughs in Science Offer Hope for Eating Disorders by Carrie ArnoldGetting Better Bite by Bite: A Survival Kit for Sufferers of Bulimia Nervosa and Binge Eating Disorder by Ulrike Schmidt, Janet Treasure & June AlexanderOvercoming Binge Eating by Christopher G FairburnBulimia Nervosa: A Cognitive Therapy Programme for Clients by Myra Cooper, Gillian Todd & Adrian WellsAnorexia nervosa. A Recovery Guide for Sufferers, Families and Friends. 2nd edition. Routledge, London and New York. A Cognitive Interpersonal Therapy Workbook for Treating Anorexia Nervosa: The Maudsley Model (MANTRA)Beating Your Eating Disorder: A Cognitive-Behavioural Self-Help Guide for Adult Sufferers and their Carers by Glenn Waller, Victoria Mountford, Rachel Lawson and Emma GrayBody Image Workbook: An eight-Step Program for Learning to Like Your looks by Thomas F. CashFor Carers:• Skills-based Learning for Caring for a Loved One with an Eating Disorder: The New Maudsley Model by Janet Treasure, Grainne Smith & Anne Crane.• Anorexia Nervosa: A Survival Guide for Families, Friends and Sufferers by Janet Treasure Eating disorders and pregnancy  http://www.eatingdisordersandpregnancy.co.uk/ Treatment Guidelines: The National Institute of Clinical Excellence (NICE) have produced treatment guidelines and a guide to these for people with eating disorders and their carers. You can look online at: https://www.nice.org.uk/guidance/ng69. Information on food and nutrition:• The British Dietetic Association  Their website provides downloadable factsheets on different foods      https://www.bda.uk.com/food-health/food-facts.html• NHS Choices – Food and dietFactsheets and information on healthy eating, including dining out. https://www.nhs.uk/live-well/ 

Today's episode highlights the work of the Simulation Labs at both the A.I. Dupont Hospital for Children in Wilmington, and the Nemours Children's Hospital in Orlando, part of the Nemours Institute for Clinical Excellence (NICE). Featured Associates: Heat

This week on MIA Radio we turn our attention to electroconvulsive therapy (known as electroshock in the US). It’s fair to say that ECT remains a controversial subject with proponents and detractors regularly disagreeing on its safety and efficacy. The number of psychiatrists willing to administer ECT, particularly in the UK, is in decline but we are still using it to administer electric shocks to the brains of an estimated 2,000 people each year. In this interview, we discuss a recent paper from the journal Ethical Human Psychology and Psychiatry. The title is ‘Electroconvulsive Therapy for Depression: A Review of the Quality of ECT versus Sham ECT Trials and Meta-Analyses’ and it is written by John Read, Irving Kirsch and Laura McGrath. On MIA we have previously written about the study and its findings. We hear from two of the authors, Professor of Psychology John Read from the University of East London and Professor of Psychology Irving Kirsch from Harvard Medical School. We discuss: That the work aimed to review the quality of meta-analyses and any relevant clinical studies of ECT. How there have only ever been 11 studies that have compared ECT with sham ECT (SECT). Sham ECT is when the anaesthetic is administered but not followed by shocks to the brain. That in addition to reviewing the quality of the studies, the paper went on to consider the effect of placebo in the administration of ECT. That when reviewing the quality of studies, a 24-point scale was used and that the scorers were blinded to each other’s ratings. The 24-point scale included 5 basic Cochrane Collaboration criteria and an additional 19 quality indicators, some of which were specific to ECT procedures. The average quality score across all the studies was 12.3 out of a 24 maximum. One of the most important findings was that none of the studies reviewed were double-blind. The reason for this is that the patients can’t be blinded to the procedure because the adverse after-effects are very obvious. In reviewing the studies it was sometimes the case that only the treating psychiatrist was rating the effectiveness of the procedure, not the patient. The 5 meta-analyses themselves only contained between 1 and 7 of the eleven available studies. The recommendation from the paper is that the use of ECT should be suspended pending a properly controlled, rigorous clinical trial. That the UK’s National Institute for Health and Clinical Excellence (NICE) has decided to review their ECT recommendations in their depression guidelines, considering the review. That the Royal College of Psychiatrists has indicated that they will update their ECT position statement in light of the review. It has come to light recently that NHS Trusts in the UK are sometimes using out of date or incorrect information in their ECT guidance leaflets, an example of this is referring to ECT correcting a ‘chemical imbalance in the brain’. How the expectations of the treating doctor can influence the condition of the person undergoing the treatment. That the placebo effect can be large and long-lasting and that the more invasive the procedure, the larger the effect. That one of the characteristics of depression is the feeling of hopelessness and that when you are given a new treatment, it can instil a sense of hope which counters the hopelessness. That the call to prohibit ECT is because the negative effects of ECT are so strong, the fact that the evidence supporting it is so weak (especially in the long-term and beyond the improvement due to placebo) and that there are other means of addressing the difficulties that the person is dealing with. That placebos are, in essence, a type of psychological therapy. Links and further reading: Electroconvulsive Therapy for Depression: A Review of the Quality of ECT versus Sham ECT Trials and Meta-Analyses Richard P. Bentall: ECT is a classic failure of evidence-based medicine NICE guidance on the use of electroconvulsive therapy

Robert Whitaker: Exercise Better Than Meds (2 of 7) Robert Whitaker makes it very clear in this segment of the interview with Dr. Mercola that exercise has proven to be more effective–and to a greater degree–at fighting depression than anti depressants. I'd like to say, right away, that this pertains only to mild to moderate depression. For severe cases, meds are more than likely going to be critically necessary. At least in the short term. And many of you will need a system like mine, in full, before exercise can have a positive effect on your depression or bipolar. Very few were exercising as hard as I was before my mind detonated. I was going downhill like a freight train with no brakes, powered by bipolar, and exercising like a demon at the same time, right before my crash. So, does this mean that I'm talking out both sides of my face? No. Here's why: What I learned, through harsh and brutal personal experience was that there were many variables that needed to be addressed, before exercise could be reasonably added to the program. When I was crashing, exercise was the ONLY good thing I was doing for myself, and it proved to not be up to the task of beating bipolar disorder by itself. Add in proper nutrition, specific nutrients, and meditation... and THEN exercise had a chance to assist! Exercise will always help. But to what degree will depend on whether or not you have the rest of your wellness ducks in a row, not to mention the severity of your illness. Some of you are just a hair off center and some regular exercise will be just the thing you need. The rest of us will need to gird out loins and do battle on a more extensive level than exercise alone. Listen to this clip and see where you might land on that spectrum. Dr. Mercola's Interview with Robert Whitaker on Mental Health (Part 2 of 7) Subscribe To AB Podcast! Sponsors: Family Network Chiropractic in Kingston, NY: The only providers of NSA Chiropractic in the Mid-Hudson Valley Maximum Results Fitness w/ Mike Romano: Online Training with Individually Customized Support Key Points: Robert Whitaker Medical Journalist Nominee for Pulitzer Prize Medical Reporter for Albany Times Union Director of Publications for Harvard Medical School Series about Psychiatry that he wrote for the Boston Globe was a finalist for the Pulitzer Prize Author of many books addressing this material Dr. Mercola Interview Content Mid-90s Ross Baldessarini: Are these drugs depressogenic? But in real life, pros everywhere seeing proof that this may be true and they DO want answers Giovanni Fava responds to Klein: Maybe YOU’RE not interested and maybe the pharmacological industry has there teeth into you, but the rest of us are interested and we’re studying it Pros everywhere finding that long term anti depressant use has a negative gain Later 90s, Duke University study: 3 groups: 1. exercise only 2. exercise and drugs 3. drugs only After 6 weeks, drugs only group doing a tiny bit better than other two 10 months later. exercise only group doing FAR better than other two, thing that drugs only harm in the long term Britain has an advisory group to the National Health Service called NICE (National Institute of Clinical Excellence) NICE released 2006 paper: at least for mild to moderate depression, anti depressants should not be the first line of therapy Program based on this allows British General Practitioners to write prescription for exercise Patient meets with exercise counselor who develops program usually for gym Gyms found to be best because they add social component which helps alleviate depression Patients get access for free or at reduced rate for 6 months Some gyms are “green” where outside work is done instead of regular exercises They found people really like this approach and stay in compliance easier than they can with drugs People feel empowered,

In June of this year, presenter of Radio 4's Woman's Hour, Jenni Murray, underwent an operation which removed 75 per cent of her stomach. A few months later, she has lost over 4 stones in weight and her symptoms of Type 2 Diabetes have gone into remission. Once a purely cosmetic procedure, bariatric surgery procedures like this have been described as the greatest advance in the history of treatment of Type 2 diabetes - so why aren't more patients being treated in this way? The National Institute of Clinical Excellence (NICE), which provides guidance and advice to the NHS, has said obese patients with diabetes should be rapidly assessed for surgery - but that's yet to happen. The treatment has been met with fierce criticism, especially from the tabloid press, which declared it undeserved: fat people should just stop eating instead of using up valuable resources to pay for vanity operations. Furthermore, Britain's leading diabetes charity, Diabetes UK, has also warned of the 'serious risks' posed by the procedure - even though the NHS has itself stated it is not more risky than a routine gall bladder operation. The irony here is that increasing the number of bariatric procedures could actually save the NHS millions of pounds, as patients are weaned off costly diabetes drugs - the NHS currently spends around £12bn a year treating the disease. With round 700 people diagnosed with diabetes in Britain every day, are we letting misguided morality get in the way of an opportunity to save money - and lives? CONTRIBUTORS INCLUDE: Jenni Murray, presenter Radio 4's Woman's Hour Simon O'Neill - Director of Health Intelligence, Diabetes UK Prof Roy Taylor, Professor of Medicine and Metabolism, Newcastle University Prof Francesco Rubino, Professor of Metabolic Surgery, King's College Hospital Prof Mark Baker, Director of the Centre for Clinical Practice, NICE Mr Andrew Mitchell, Consultant General Surgeon, Darlington Memorial Hospital Presenter: Adrian Goldberg Producer: Richard Fenton-Smith Note: A version of this programme was first broadcast on BBC Radio 4 in June, 2014.

Around 700 people are diagnosed with diabetes in Britain every day, and the condition accounts for around 10 per cent of the NHS budget - but is enough being done to combat the effects of the disease? The National Institute of Clinical Excellence - NICE - is the body which provides guidance and advice to the NHS. It recently published new draft guidelines which proposed increasing access to weight-loss surgery to a wider range of patients diagnosed with type 2 diabetes. This announcement was met with fierce criticism, especially from the tabloid press, which declared such treatment as undeserved: fat people should just stop eating instead of using up valuable resources to pay for vanity operations. But some experts say bariatric surgery is the most important development in the history of diabetes treatment and its effectiveness can lead to full remission of type 2 diabetes. In turn, this could end up saving the NHS millions of pounds as patients are weaned off costly drugs, and are less likely to develop complications such as blindness or kidney failure. But is this really a long-term solution? Or do we need to think more radically about how to educate the public about healthy living to really reduce the rapid rise in diabetes diagnoses? CONTRIBUTORS INCLUDE: Simon O'Neill - Director of Health Intelligence, Diabetes UK Prof Roy Taylor, Professor of Medicine and Metabolism, Newcastle University Prof Francesco Rubino, Professor of Metabolic Surgery, King's College Hospital Prof Mark Baker, Director of the Centre for Clinical Practice, NICE Mr Andrew Mitchell, Consultant General Surgeon, Darlington Memorial Hospital Reporter: Adrian Goldberg Producer: Richard Fenton-Smith.

The 2010 Healthcare Forum series commenced on 11th March with a lecture on the topic of Cognitive Behaviour Therapy, delivered by Henck van Bilsen. Henck van Bilsen is a consultant in CBT and consultant Clinical Psychologist, specialising in complex and long-standing problems. Cognitive Behaviour Therapy (CBT) is the psychological treatment of choice for many mental health problems, the NHS National Institute for Clinical Excellence (NICE) recommends CBT as the best treatment for anxiety and depression.

Estimates of HIV are just that, estimates – but in order to research the progression of the virus, and the effectiveness of intervention strategies, those estimates have to be as accurate as possible. Professor Prabhat Jha joins us to explain the novel way in which he and his team have collected data in India to provide a more accurate picture about the spread of the virus. Also this week, as spending cuts are planned across public services, the financial strain on the UK health service is increasing. One way in which some money can be saved is through disinvestment; ceasing treatments which have been superseded, or shown ineffective. Peter Littlejohns, the clinical and public health director of the National Institute for Health and Clinical Excellence (NICE), joins us to explain what NICE is doing in that arena. Annabel Ferriman takes us through the news.

A BMJ investigation this week raises concerns about the ability of the US Food and Drug Administration to monitor the safety of medical devices through post-approval surveillance. We ask: is the FDA giving device manufacturers an easy regulatory ride? Also, the National Institute for Health and Clinical Excellence (NICE) is set to lose the power to restrict the use of any drug that exceeds its £30k cost per quality adjusted life year ceiling. Alan Maynard, professor of health economics at the University of York, discusses what this will mean.

How can doctors and police sharing information help stop violent crime? Jonathan Shepherd, from Cardiff University, explains the Cardiff Violence Prevention Programme - and his research into its effectiveness. Also this week, as a new antiplatelet agent is being considered by the National Institute for Health and Clinical Excellence (NICE), Albert Ferro, from King's College London, takes us through this class of drugs, their effectiveness, and their indications.

Wendy Jarrett, Associate Director, Media Relations, National Institute for Clinical Excellence (NICE) gives a talk for the Communicating Risk and Uncertainty conference, held at Green Templeton College, Oxford.

Wendy Jarrett, Associate Director, Media Relations, National Institute for Clinical Excellence (NICE) gives a talk for the Communicating Risk and Uncertainty conference, held at Green Templton College, Oxford.